About This Article
An article published in Clinical Pharmacology & Therapeutics, co-authored by ProSciento and Youngene Therapeutics, discusses findings from a study that examined the effects of two different SGLT inhibitors alongside insulin in individuals with type 1 diabetes. The randomized crossover trial investigated how YG1699 and dapagliflozin influenced glucose levels in type 1 diabetes patients using pump therapy. Results show YG1699 significantly lowered post-prandial glucose levels compared to dapagliflozin, with reduced insulin dose requirements.
![A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin thumbnail](https://prosciento.com/wp-content/uploads/2024/03/ascpt-randomized_crossover_trial.jpg)
Recommended Materials
![A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin thumbnail](https://prosciento.com/wp-content/uploads/2022/04/pharmacodynamics_novel_insulin_dimer.jpg)
Articles
A randomized, single ascending dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of a novel insulin dimer
![A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin thumbnail](https://prosciento.com/wp-content/uploads/2021/09/703-EASD-Presentation-Cover-Landing-Page.jpg)
Posters
Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of INS068 vs Insulin Degludec in Type 1 Diabetes at Steady State: a Phase I, Randomized, Double-blind, Cross-over Trial
![A Randomized Crossover Trial of Mixed Meal Tolerance Test Response in People with Type 1 Diabetes on Insulin Pump Therapy and YG1699 or Dapagliflozin thumbnail](https://prosciento.com/wp-content/uploads/2021/09/424-EASD-Presentation-Cover-Landing-Page.jpg)
Posters
A First in Human, Single Ascending Dose Study to Assess the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of AB101 in Subjects with Type 1 Diabetes​
Related Solutions
![Glucose, Lipid And Mixed-meal Tolerance Tests thumbnail](https://prosciento.com/wp-content/uploads/2023/08/specialized-methods-glucose-lipid-and-mixed-meal-tolerance-tests.jpg)
Specialized Methods
![Diabetes thumbnail](https://prosciento.com/wp-content/uploads/2023/08/our-metabolic-focus-diabetes-thumbnail.jpg)